Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	392.87	50.85	10.32
Graham Fair Price	-63.71	36.70	101.13
PEG	3795.56	0.07	< 0.005
Price/Book	-7.94	0.50	0.54
Price/Cash Flow	-14.44	-23.29	27.22
Prices/Earnings	-615.82	-5.82	-0.81
Price/Sales	-16.75	1.42	1.71
Price/FCF	-14.44	-23.29	27.22
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	7.85	0.17	0.16
Operating Margin	40.93	-0.02	-0.04
ROA	86.18	-0.01	-0.07
ROE	-0.17	-0.02	87.14
ROIC	< 0.005	< 0.005	47.09
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	83.30
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.09	0.34	267.23
EPS QOQ	-4.74	0.87	-81.62
FCF QOQ	-0.72	-2.09	-189.92
Revenue QOQ	-0.10	0.12	15.54
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	101.66	91.83	-9.67
Days Sales Outstanding (DSO)	64.18	47.88	-25.39
Inventory Turnover	0.89	0.98	10.70
Debt/Capitalization	0.39	0.40	2.47
Quick Ratio	1.29	1.03	-20.13
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	52.13	52.75	1.20
Cash	5.74	4.48	-21.98
Capex	-1.53	-0.45	70.45
Free Cash Flow	1.04	-1.13	8.89
Revenue	16.63	18.61	11.91
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.48	2.48	0.24
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.56	28.26	408.12
Naive Interpretation	Member

06 - Financial Health · Bad

Rating